Project Grant R21CA290223
Award Date
4/12/25
Completion Date
3/31/27
Dollars Obligated
$228K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This federal Project Grant award, valued at $398,207.00 and provided by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), aims to develop and test a multilevel intervention to improve interdisciplinary communication quality in low-resource pediatric oncology hospitals. The key products and services to be delivered under this five-year grant include: Conducting a cross-sectional social network analysis across 20 hospitals to identify the relationship between...
The National Cancer Institute (NCI) awarded a 5-year, $185,693 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Research Institute at Nationwide Children's Hospital (RINCH) in Columbus, Ohio. The grant, titled "A Digital Health Parent Coaching Intervention to Improve Neurodevelopmental Outcomes for Young Childhood Cancer Survivors in Underserved Communities," aims to develop and evaluate a digital health program that provides parent coaching to improve...
The National Cancer Institute (NCI) awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a hybrid type I cluster randomized effectiveness-implementation trial of the CARES intervention, an integrated EHR-based screening and stepped collaborative care program designed to improve health-related quality of life for cancer patients experiencing depression, pain, and fatigue. The overarching...
The National Cancer Institute (NCI) awarded a $1,128,600 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Utah to develop and evaluate a mobile health (mHealth) intervention called "Color Me Healthy" to improve symptom communication for children with cancer during the early cancer treatment period. The project aims to create a clinician-facing app that integrates with electronic health record (EHR) systems to allow review and...
The National Cancer Institute (NCI) awarded a $290,052 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the Regents of the University of Michigan. The grant will fund the development and evaluation of a mobile-optimized "Personalized Cancer Support for Young Adults" (PERCS-YA) intervention tool. This tool aims to reduce worry and distress among young adult cancer survivors of thyroid, melanoma, and testicular cancer through improved...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This Project Grant award of $2,044,728 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a comprehensive investigation into the genetic underpinnings of pediatric cancers. The research team at St. Jude Children's Research Hospital will leverage existing genetic datasets on over 43,000 pediatric cancer cases spanning more than 25 cancer subtypes. The key objectives are to: 1) Conduct a systematic search for common genetic...
The National Cancer Institute (NCI) awarded a Cooperative Agreement grant (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $662,761 to the Dartmouth-Hitchcock Clinic to conduct the "VIDEO INSPIRED DISCUSSIONS ABOUT ETHICAL OUTCOMES IN PEDIATRICS (VIDEO-PEDS)" project. The goal is to build infrastructure and conduct a large randomized trial to evaluate the impact of a goals-of-care video decision aid for parents of children with cancer. The project will involve...
The National Cancer Institute (NCI) awarded a $563,130 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of California, Davis (UC Davis) to identify barriers and facilitators to delivering guideline-concordant care for adolescents and young adults (AYAs) with Ewing sarcoma and osteosarcoma. The key objectives of this 5-year project are to: 1) Identify barriers and facilitators to delivering guideline-concordant care for AYAs with these rare cancers; 2)...
The National Cancer Institute (NCI) awarded a $1,909,966 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Xanthoshealth, Inc. for the "CONNECTEDNEST: A Digital Platform Connecting Individuals with Cancer to Social Care" project. The project aims to enhance a digital social care referral platform developed by Xanthoshealth to address the impact of social determinants of health on individuals facing cancer. Key objectives include upgrading the...